To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Veeva by 720 shares, the number of shares held increased 1.7% compared to the previous period and now represents 0.61% of the total position.
      11Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 465 shares, the number of shares held increased 1.73% compared to the previous period and now represents 1.04% of the total position.
      9Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Incyte by 2,430 shares, the number of shares held increased 1.72% compared to the previous period and now represents 1.18% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Atai Beckley Inc by 59,130 shares, the number of shares held increased 1.73% compared to the previous period and now represents 1.02% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 199,635 shares, the number of shares held increased 1.73% compared to the previous period and now represents 1.77% of the total position.
      5.85K2
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Amgen by 795 shares, the number of shares held increased 1.7% compared to the previous period and now represents 1.42% of the total position.
      14Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 4,860 shares, the number of shares held increased 1.73% compared to the previous period and now represents 2.12% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Butterfly Network Inc by 111,630 shares, the number of shares held increased 1.73% compared to the previous period and now represents 1.64% of the total position.
      64Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 89,340 shares, the number of shares held increased 1.73% compared to the previous period and now represents 1.43% of the total position.
      14Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 37,965 shares, the number of shares held increased 1.73% compared to the previous period and now represents 2.06% of the total position.
      7Comment
      Report
      • empty
        No followers yet
       
       
       
       

      Most Discussed